Accuray Inc. (ARAY) Tops Q3 EPS by 10c; Boosts FY14 Revs Outlook
Tweet
Share
E-mailGet Alerts ARAY Hot Sheet
Price: $0.28 --0%
EPS Growth %: -400.0%
Financial Fact:
Research and development: 12.23M
Today's EPS Names:
OTLK, EGRX, MOVE, More
EPS Growth %: -400.0%
Financial Fact:
Research and development: 12.23M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Accuray Inc. (NASDAQ: ARAY) reported Q3 EPS of ($0.06), $0.10 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $97.1 million versus the consensus estimate of $82 million.
Accuray Inc. sees FY2014 revenue of $355-365 million, versus prior guidance of $340-350 million and the consensus of $345.8 million.
For earnings history and earnings-related data on Accuray Inc. (ARAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
